Analystreport

Arcus Biosciences (NYSE:RCUS) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

Arcus Biosciences, Inc.  (RCUS) 
Last arcus biosciences, inc. earnings: 3/5 04:10 pm Check Earnings Report